Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

NCT01533077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 9-1067
DRUG: Sinemet® 100/25 mg

Sponsor

Bial - Portela C S.A.